Developer:
Monsanto Company (including fully and partly owned companies)

Method of Trait Introduction:
Agrobacterium tumefaciens-mediated plant transformation

GM Trait s :
Lepidopteran insect resistance , Antibiotic resistance

Commercial Trait:
(Singular)  Insect Resistance

Summary of Basic Genetic Modification

Gene Introduced	Gene Source	Product	Function
cry1Ac	Bacillus thuringiensis subsp. Kurstaki strain HD73	Cry1Ac delta-endotoxin	confers resistance to lepidopteran insects by selectively damaging their midgut lining
nptII  *	Escherichia coli Tn5 transposon	neomycin phosphotransferase II enzyme	allows transformed plants to metabolize neomycin and kanamycin antibiotics during selection
aad  *	Escherichia coli	3''(9)-O-aminoglycoside adenylyltransferase enzyme	allows selection for resistance to aminoglycoside antibiotics such as spectinomycin and streptomycin

 * : Selection Marker/Reporter  

Summary of Regulatory Approvals: Country, Year and Type of Approval

Country	Food direct use or processing	Feed direct use or processing	Cultivation domestic or non-domestic use
Australia
Canada
Japan
New Zealand
South Africa
South Korea
United States of America

 

Event Description

• CBD Biosafety Clearing House
• CERA GM Crop Database

Regulatory and Biosafety Information

• Canadian Food Inspection Agency
• Center for Environmental Risk Assessment
• Food Standards Australia New Zealand
• Japan Biosafety Clearing House
• US Department of Agriculture - APHIS
• US Food and Drug Administration
• US Food and Drug Administration

Detection Methods

• GMO Detection Method Database